Ezetimibe, a promising lipid-lowering agent for the treatment of dyslipidaemia in HIV-infected patients with poor response to statins.
Negredo, E., Moltó, J., Puig, J., Cinquegrana, D., Bonjoch, A., Pérez-Álvarez, N., López-Blázquez, R., Blanco, A., Clotet, B., Rey-Joly, C. (2006). AIDS 20 (17), 2159-2164.
https://grass.upc.edu/en/publications/selection-of-publications/ezetimibe-a-promising-lipid-lowering-agent-for-the-treatment-of-dyslipidaemia-in-hiv-infected-patients-with-poor-response-to-statins
https://grass.upc.edu/++resource++plone-logo.svg
Ezetimibe, a promising lipid-lowering agent for the treatment of dyslipidaemia in HIV-infected patients with poor response to statins.
Negredo, E., Moltó, J., Puig, J., Cinquegrana, D., Bonjoch, A., Pérez-Álvarez, N., López-Blázquez, R., Blanco, A., Clotet, B., Rey-Joly, C. (2006). AIDS 20 (17), 2159-2164.
Share: